Novabay Pharmaceuticals Inc.
13F holders, Q4 2024 (December 31)16holders +3
4new positions
2sold out
$0.60avg. 13F price*
At the end of Q4 2024, 16 institutions reported holding Novabay Pharmaceuticals Inc. in their 13F filings, up 3 from Q3 2024. 4 opened new positions and 2 sold out. The largest holders were C2C Wealth Management, LLC ($31K), Geode Capital Management, LLC ($20K) and Two Sigma Securities, LLC ($19K).
- Company
- Novabay Pharmaceuticals Inc.
- CUSIP
- 66987P409
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $29K |
| Exits | 2 | $21K |
All 13F filers, Q3 2024 → Q4 2024: 72,102 shares bought and 31,092 shares sold, net +41,010 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| C2C Wealth Management, LLC | 0.03% | Add +18.5% | 50,902 | $31K |
| Geode Capital Management, LLC | 0.00% | Add +25.4% | 33,030 | $20K |
| Two Sigma Securities, LLC | 0.00% | New | 31,411 | $19K |
| Virtu Financial LLC | 0.00% | Add +41.5% | 27,719 | $17K |
| XTX Topco Ltd | 0.00% | New | 16,138 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.6% | 5,451 | $3K |
| Morgan Stanley | 0.00% | Add +305.6% | 2,040 | $1K |
| JPMorgan Chase & Co. | 0.00% | New | 239 | $144 |
| SBI Securities Co., Ltd. | 0.00% | — | 50 | $30 |
| Bank of America Corp. | 0.00% | No change | 42 | $25 |
| Nvwm, LLC | 0.00% | No change | 3 | $2 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1 | $1 |
| Allworth Financial LP | 0.00% | New | 1 | $1 |
| Addison Advisors LLC | 0.00% | No change | 1 | $1 |
| Blue Trust, Inc. | 0.00% | No change | 2 | $1 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is NOVABAY PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Novabay Pharmaceuticals Inc. the manager owns.